Coumarin

CHEMBL6466 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
146.1 g/mol
LogP
1.4
Phase
4

A naturally occurring fragrant compound found in many plants, which at high doses inhibits the production of vitamin K-dependent clotting factors and has anticoagulant properties. It is the parent compound of warfarin and related anticoagulant drugs but is itself not used therapeutically as an anticoagulant due to concerns about liver toxicity. It is mainly encountered as a fragrance ingredient.

分子量

146.1400 g/mol

LogP

1.40

TPSA

26.30 Ų

リピンスキーの五則

適合

治療領域

作用機序

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=c1ccc2ccccc2o1

InChI

InChI=1S/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6H

Molecular Formula

C9H6O2

HBD / HBA

- / 2

回転可能結合数

0

重原子数

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A naturally occurring fragrant compound found in many plants, which at high doses inhibits the production of vitamin K-dependent clotting factors and has anticoagulant properties. It is the parent compound of warfarin and related anticoagulant drugs but is itself not used therapeutically as an anticoagulant due to concerns about liver toxicity. It is mainly encountered as a fragrance ingredient.

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Yes, Coumarin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6466. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 323. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.